188 related articles for article (PubMed ID: 12513924)
1. Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus.
McGuire TC; Fraser DG; Mealey RH
Viral Immunol; 2002; 15(4):521-31. PubMed ID: 12513924
[No Abstract] [Full Text] [Related]
2. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.
O'Rourke KI; Perryman LE; McGuire TC
Vet Immunol Immunopathol; 1989 Nov; 23(1-2):41-9. PubMed ID: 2559537
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.
Taylor SD; Leib SR; Wu W; Nelson R; Carpenter S; Mealey RH
J Virol; 2011 Jul; 85(13):6814-8. PubMed ID: 21543497
[TBL] [Abstract][Full Text] [Related]
4. Studies on complement-fixation reaction in equine infectious anemia. I. Development and activities of complement-fixing and complement fixation-inhibiting antibodies.
Nakamura J; Kuroda S; Ueda S; Samejima T
Jpn J Microbiol; 1974 Sep; 18(5):385-95. PubMed ID: 4374566
[No Abstract] [Full Text] [Related]
5. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
[TBL] [Abstract][Full Text] [Related]
6. [Study on the role of cytotoxic T lymphocytes during equine infectious anemia virus infection and its epitope specificity].
Ma J; Kong XG; Shen RX; Zhou JH
Bing Du Xue Bao; 2007 Jan; 23(1):76-8. PubMed ID: 17886727
[No Abstract] [Full Text] [Related]
7. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.
Taylor SD; Leib SR; Carpenter S; Mealey RH
J Virol; 2010 Jul; 84(13):6536-48. PubMed ID: 20392850
[TBL] [Abstract][Full Text] [Related]
8. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to herpesvirus types 1 and 2, arteritis and infectious anemia viral antigens in equine serum.
McGuire TC; Crawford TB; Henson JB
Am J Vet Res; 1974 Feb; 35(2):181-5. PubMed ID: 4360338
[No Abstract] [Full Text] [Related]
10. Hemagglutination-inhibition tests with different strains of equine infectious anemia virus.
Sentsui H; Kono Y
Am J Vet Res; 1981 Nov; 42(11):1949-52. PubMed ID: 6175255
[TBL] [Abstract][Full Text] [Related]
11. Responses in horses infected with equine infectious anemia virus adapted to tissue culture.
Gutekunst DE; Becvar CS
Am J Vet Res; 1979 Jul; 40(7):974-7. PubMed ID: 228570
[No Abstract] [Full Text] [Related]
12. Antibody escape kinetics of equine infectious anemia virus infection of horses.
Schwartz EJ; Nanda S; Mealey RH
J Virol; 2015 Jul; 89(13):6945-51. PubMed ID: 25878104
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
McGuire TC; Fraser DG; Mealey RH
Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
[TBL] [Abstract][Full Text] [Related]
14. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
[TBL] [Abstract][Full Text] [Related]
15. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
[TBL] [Abstract][Full Text] [Related]
17. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses.
McGuire TC; Leib SR; Lonning SM; Zhang W; Byrne KM; Mealey RH
J Gen Virol; 2000 Nov; 81(Pt 11):2735-2739. PubMed ID: 11038386
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of equine infectious anemia virus escape from neutralizing antibody responses define epitope specificity.
Sponseller BA; Clark SK; Friedrich RA
Viral Immunol; 2012 Aug; 25(4):324-8. PubMed ID: 22746986
[TBL] [Abstract][Full Text] [Related]
19. Viremia and immunological responses in horses infected with equine infectious anemia virus.
Kono Y
Natl Inst Anim Health Q (Tokyo); 1969; 9(1):1-9. PubMed ID: 4306393
[No Abstract] [Full Text] [Related]
20. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
Tschetter JR; Byrne KM; Perryman LE; McGuire TC
Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
